Tag Archive for: colon cancer

If approved, the test, called Shield, could become the second blood-based test for CRC screening in the United States after Epigenomics’ Epi proColon, which was approved in 2016.

With the approval, Tukysa became the first FDA-approved treatment for RAS wild-type, HER2-positive metastatic colon cancer, a cancer with historically poor outcomes.